Corporate Responsibility

We apply our expertise in science and innovation to society’s biggest health challenges. Corporate responsibility is a core part of our business strategy.

In this section

Novartis in Society US Reports: Novartis has a strong history of CR activities, and transparent reporting is a central part of our commitment to corporate responsibility.
Corporate Citizenship: Social responsibility at Novartis Pharmaceuticals Corporation is an integral part of how we operate and a key to our success.
Business Conduct: NPC has established and maintains an effective compliance program that is based on the highest ethical standards and in accordance with federal, state, and industry regulations and guidelines.
Corporate Integrity Agreement: NPC's Corporate Integrity Agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services expands upon our already strong commitment to sustainable performance built on a solid foundation of ethical behavior at all levels of business.
Payments to HCPs & HCOs: The Sunshine Act was enacted by Congress in 2010 as part of the Patient Protection and Affordable Care Act, or the healthcare reform law, and is intended to provide more transparency in the relationships between the healthcare industry and physicians and teaching hospitals.
Post-Marketing Commitments: As part of the US regulatory approval process, sponsors may agree or be required to conduct additional studies following FDA approval of a drug for marketing.
Enhanced Verification Request: The Drug Supply Chain Security Act (DSCSA) created national requirements for tracing pharmaceutical products and includes a provision for enhanced verification, by which trading partners may request manufacturers to verify unit-level product identifiers.

Quick Links

Corporate Citizenship

Patients

Corporate Citizenship

People and Communities

Business Conduct

Compliance

Business Conduct

State Laws

Careers

Our mission is to discover new ways to improve and extend people's lives.